Erratum to "Could B-type Natriuretic Peptide (BNP) plasma concentration be useful to predict fluid in critically ill patients with acute circulatory failure?" [Ann Fr Anesth Reanim 28(6) (2009) 531-6] (DOI:10.1016/j.annfar.2009.04.003);Could B-type Natriuretic Peptide (BNP) plasma concentration be useful to predict fluid in critically ill patients with acute circulatory failure?

Annales Francaises d'Anesthesie et de Reanimation

Volumn 28, Issue 6, 2009, Pages 531-536

  Muller, L ^a   Louart, G ^a   Teboul, J L ^b   Mahamat, A ^a   Polge, A ^a   Bertinchant, J P ^a   Ripart, J ^a   de La Coussaye, J E ^a   Lefrant, J Y ^a  

^a NÎMES UNIVERSITY HOSPITAL   (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

B type Natriuretic Peptide; Fluid responsiveness

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ACCURACY; ACUTE DISEASE; ADULT; AGED; ARTICLE; BODY FLUID; CENTRAL VENOUS PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; FEMALE; HEART OUTPUT MEASUREMENT; HEART PRELOAD; HEART STROKE VOLUME; HUMAN; ISCHEMIA; MALE; PREDICTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REFERENCE VALUE; SEDATION; SENSITIVITY AND SPECIFICITY;

EID: 67649398757     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2009.08.001     Document Type: Erratum

References (23)

1. Wiese S., Breyer T., Dragu A., Wakili R., Burkard T., Schmidt-Schweda S., et al. Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length. Circulation 102 (2000) 3074-3079
2. Maisel A.S., Krishnaswamy P., Nowak R.M., McCord J., Hollander J.E., Duc P., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
3. Mueller C., Scholer A., Laule-Kilian K., Martina B., Schindler C., Buser P., et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350 (2004) 647-654
4. Charpentier J., Luyt C.E., Fulla Y., Vinsonneau C., Cariou A., Grabar S., et al. Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 32 (2004) 660-665
5. Roch A., Allardet-Servent J., Michelet P., Oddoze C., Forel J.M., Barrau K., et al. NH2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients. Crit Care Med 33 (2005) 1001-1007
6. McLean A.S., Huang S.J., and Salter M. Bench-to-bedside review: the value of cardiac biomarkers in the intensive care patient. Crit Care 12 (2008) 215
7. Jourdain P., Funck F., Bellorini M., Guillard N., Loiret J., Thebault B., et al. Bedside B-type natriuretic peptide and functional capacity in chronic heart failure. Eur J Heart Fail 5 (2003) 155-160
8. Kazanegra R., Cheng V., Garcia A., Krishnaswamy P., Gardetto N., Clopton P., et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail 7 (2001) 21-29
9. Michard F., Boussat S., Chemla D., Anguel N., Mercat A., Lecarpentier Y., et al. Relation between respiratory changes in arterial pulse pressure and fluid responsiveness in septic patients with acute circulatory failure. Am J Respir Crit Care Med 162 (2000) 134-138
10. Vincent J.L., and Gerlach H. Fluid resuscitation in severe sepsis and septic shock: an evidence-based review. Crit Care Med 32 (2004) S451-S454
11. Tavernier B., Makhotine O., Lebuffe G., Dupont J., and Scherpereel P. Systolic pressure variation as a guide to fluid therapy in patients with sepsis-induced hypotension. Anesthesiology 89 (1998) 1313-1321
12. Phua J., Lim T.K., and Lee K.H. B-type natriuretic peptide: issues for the intensivist and pulmonologist. Crit Care Med 33 (2005) 2094-2113
13. McLean A.S., Tang B., Nalos M., Huang S.J., and Stewart D.E. Increased B-type natriuretic peptide (BNP) level is a strong predictor for cardiac dysfunction in intensive care unit patients. Anaesth Intensive Care 31 (2003) 21-27
14. Tung R.H., Garcia C., Morss A.M., Pino R.M., Fifer M.A., Thompson B.T., et al. Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock. Crit Care Med 32 (2004) 1643-1647
15. Michard F., and Teboul J.L. Predicting fluid responsiveness in ICU patients: a critical analysis of the evidence. Chest 121 (2002) 2000-2008
16. Dellinger R.P., Levy M.M., Carlet J.M., Bion J., Parker M.M., Jaeschke R., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med 36 (2008) 296-327
17. Mekontso-Dessap A., Tual L., Kirsch M., D'Honneur G., Loisance D., Brochard L., et al. B-type natriuretic peptide to assess haemodynamic status after cardiac surgery. Br J Anaesth 97 (2006) 777-782
18. Pirracchio R., Deye N., Lukaszewicz A.C., et al. Impaired plasma B-type natriuretic peptide clearance in human septic shock. Crit Care Med 36 (2008) 2542-2546
19. Verdier B., Chauvet J.L., Tamion F., Cauliez B., Lavoinne A., Veber B., et al. Évaluation du NT-proBNP comme marqueur biologique de la dysfonction cardiaque du choc septique. Ann Fr Anesth Reanim 27 (2008) 135-140
20. Rudiger A., Gasser S., Fischler M., Hornemann T., von Eckardstein A., and Maggiorini M. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med 34 (2006) 2140-2144
21. Roch A. What does high NT-proBNP mean in septic shock patients? A part of the puzzle. Crit Care 11 (2007) 122
22. Heringlake M, Heide C, Bahlmann L, Eichler W, Pagel H, Schmucker P, et al. Effects of tilting and volume loading on plasma levels and urinary excretion of relaxin, NT-pro-ANP, and NT-pro-BNP in male volunteers. J Appl Physiol. 2004;97:173-9. Epub 2004 Feb 27.
23. McNairy M., Gardetto N., Clopton P., Garcia A., Krishnaswamy P., Kazanegra R., et al. Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure: implications for outpatient monitoring with B-type natriuretic peptide. Am Heart J 143 (2002) 406-411